Startseite Medizin The n-3 and n-6 Polyunsaturated Fatty Acid Composition of Plasma Phospholipids in Pregnant Women and Their Infants. Relationship with Maternal Linoleic Acid Intake
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The n-3 and n-6 Polyunsaturated Fatty Acid Composition of Plasma Phospholipids in Pregnant Women and Their Infants. Relationship with Maternal Linoleic Acid Intake

  • Patrick Rump und Gerard Hornstra
Veröffentlicht/Copyright: 1. Juni 2005
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 40 Heft 1

Abstract

The availability of long-chain polyunsaturated fatty acids during infancy has been related to neonatal growth and development. Fatty acid concentration at birth is an important predictor of postnatal level. The primary aim of this study was to provide a description of the distribution of n−3 and n−6 polyunsaturated fatty acids in the plasma phospholipid fraction of pregnant women remaining on a Western-style diet and their neonates. The plasma phospholipid polyunsaturated fatty acid composition was determined by gas-liquid chromatography in 889 mother-infant pairs. Blood samples were taken during the first, second and third trimester of pregnancy, at delivery, and from the umbilical vein at birth. Mean (±SD) fatty acid concentrations are reported in mg/l and as percentage of total fatty acids (% wt/wt). In addition, the 10th, 25th, 50th, 75th and 90th percentiles are given. The distribution of docosahexaenoic acid (22:6n−3) and arachidonic acid (20:4n−6) concentrations in umbilical plasma phospholipids is also reported as a function of gestational age and maternal linoleic acid intake during pregnancy. This data can be be used as a reference for future studies and may aid in identifying term infants with a relatively low long-chain polyene status at birth.

:
Published Online: 2005-06-01
Published in Print: 2002-01-29

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. Editorial
  2. Growing Significance of Myeloperoxidase in Non-infectious Diseases
  3. Serum Paraoxonase Activity and the Extent of Lipid Peroxidation Are not Affected by Increased Levels of Human Apolipoprotein A-I: Studies in Transgenic Mice
  4. Relationship between the Sialic Acid Content of Low-Density Lipoprotein (LDL) and Autoantibodies to Oxidized LDL in the Plasma of Healthy Subjects and Patients with Atherosclerosis
  5. The Presence of Heparin-Platelet Factor 4 Antibodies as a Marker of Hypercoagulability during Hemodialysis
  6. Clinical Evaluation of Changes in the Morphology of Eosinophils
  7. The n-3 and n-6 Polyunsaturated Fatty Acid Composition of Plasma Phospholipids in Pregnant Women and Their Infants. Relationship with Maternal Linoleic Acid Intake
  8. Quantification of Sirolimus by Liquid Chromatography-Tandem Mass Spectrometry Using On-Line Solid-Phase Extraction
  9. The Effects of Affinity-Purified Anti-DNA Antibodies Derived from Patients with Systemic Lupus Erythematosus on the Fluorescent Antinuclear Antibody Assay Using HEp-2 Cells
  10. Relationships between Serum Markers of Monocyte/Macrophage Activation in Type 1 Gaucher's Disease
  11. Gender Differences in C-Reactive Protein Concentrations - Confirmation with Two Sensitive Methods
  12. Serum Cholinesterase Activity in Patients with Burns
  13. Serum Lipids and Apolipoproteins in Patients with Psoriasis
  14. Reference Intervals for a Complete Blood Count Determined on different Automated Haematology Analysers: Abx Pentra 120 Retic, Coulter Gen-S, Sysmex SE 9500, Abbott Cell Dyn 4000 and Bayer Advia 120
  15. Science, Alchemy and Light: Paintings by Joseph Wright of Derby
  16. Approved IFCC Reference Method for the Measurement of HbA1c in Human Blood
  17. Meetings and Awards
Heruntergeladen am 30.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.007/html?lang=de
Button zum nach oben scrollen